04 October 2021 | News
The company will focus on ROW markets like Africa, LATAM, South East Asia and CIS countries and planning to file over 180 dossiers
Ahmedabad-based Uniza Healthcare has launched a novel treatment for the management of Vitiligo, a pigmentary skin disorder, in Indian market.
The company has launched a lotion - Vitellus, a unique combination of Greyverse, Melitane GL 200 & EUK-134 in tie-up with a Canadian company - Lucas Meyer Cosmetics and Indian company Amvigor Organics. The company has recently received WHO GMP Certification for its Kadi Plant.
Vitellus lotion is a 3 in 1 solution and helps in growth of melamine and works on skin pigmentation, hair follicle pigmentation and also as a super antioxidant. Greyverse stimulates melanogenesis and pigmentation and decreases in oxidative stress, EUK - 134 decreases oxidative stress and H2O2 Production while Melitane helps in promoting re-pigmentation of skin by stimulating melanogenesis and decreasing inflammation.
Sreekanth Seshadri, CEO and Managing Partner, Uniza Healthcare, said, "Vitellus is an advanced solution for the management of Vitiligo as compared to currently available. Company is looking to introduce more innovative products in India."
"Our international business would mainly focus on ROW markets like Africa, LATAM, South East Asia and CIS countries and planning to file over 180 dossiers. Our Indian business is aiming to achieve sales of Rs 100 crore in FY 2021-22," said Saurin Parikh, MD, Uniza Group & Founder, Pashupati Group.